Cancer Preventive Effects of Green Tea Polyphenols

Polyphenols in Human Health and Disease

Volumn 2, Issue , 2013, Pages 1309-1322

  Forester, Sarah C ^a   Lambert, Joshua D ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Cancer; EGCG; Green tea; Polyphenols; Reactive oxygen species

Indexed keywords

EID: 84902571981     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-398456-2.00098-0     Document Type: Chapter

References (135)

1. Yang C.S., Wang X., Lu G., Picinich S.C. Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat Rev Cancer 2009, 9(6):429-439.
2. Valcic S., Timmermann B.N., Alberts D.S., Wachter G.A., Krutzsch M., Wymer J., et al. Inhibitory effect of six green tea catechins and caffeine on the growth of four selected human tumor cell lines. Anticancer Drugs 1996, 7(4):461-468.
3. Baptista J.A.B., Tavares J.F.D., Carvalho R.C.B. Comparison of catechins and aromas among different green teas using HPLC/SPME-GC. Food Res Int 1998, 31(10):729-736.
4. Shishikura Y., Khokhar S. Factors affecting the levels of catechins and caffeine in tea beverage: estimated daily intakes and antioxidant activity. J Sci Food Agric 2005, 85(12):2125-2133.
5. Engelhardt U.H., Lakenbrink C., Pokorny O. Proanthocyanidins. bisflavanols, and hydrolyzable tannins in green and black teas. Nutraceutical Beverages: Chemistry, Nutrition, and Health Effects 2004, 254-264. American Chemical Society, Washington. F. Shahidi, D.K. Weerasinghe (Eds.).
6. Imai K., Suga K., Nakachi K. Cancer-preventive effects of drinking green tea among a Japanese population. Prev Med 1997, 26(6):769-775.
7. Nakachi K., Matsuyama S., Miyake S., Suganuma M., Imai K. Preventive effects of drinking green tea on cancer and cardiovascular disease: epidemiological evidence for multiple targeting prevention. Biofactors 2000, 13(1-4):49-54.
8. Nagano J., Kono S., Preston D.L., Mabuchi K. A prospective study of green tea consumption and cancer incidence, Hiroshima and Nagasaki (Japan). Cancer Cause Control 2001, 12(6):501-508.
9. Nagano J., Kono S., Preston D.L., Mabuchi K. A prospective study of green tea consumption and cancer incidence, Hiroshima and Nagasaki (Japan). Cancer Cause Control 2001, 12(6):501-508.
10. Ogunleye A.A., Xue F., Michels K.B. Green tea consumption and breast cancer risk or recurrence: a meta-analysis. Breast Cancer Res Treat 2010, 119(2):477-484.
11. Suzuki Y., Tsubono Y., Nakaya N., Koizumi Y., Tsuji I. Green tea and the risk of breast cancer: pooled analysis of two prospective studies in Japan. Br J Cancer 2004, 90(7):1361-1363.
12. Yuan J.M., Koh W.P., Sun C.L., Lee H.P., Yu M.C. Green tea intake, ACE gene polymorphism and breast cancer risk among Chinese women in Singapore. Carcinogenesis 2005, 26(8):1389-1394.
13. Wu A.H., Tseng C.C., Van Den Berg D., Yu M.C. Tea intake, COMT genotype, and breast cancer in Asian-American women. Cancer Res 2003, 63(21):7526-7529.
14. Iwasaki M., Inoue M., Sasazuki S., Sawada N., Yamaji T., Shimazu T., et al. Green tea drinking and subsequent risk of breast cancer in a population to based cohort of Japanese women. Breast Cancer Res 2010, 12(5):R88.
15. Inoue M., Robien K., Wang R.W., Van Den Berg D.J., Koh W.P., Yu M.C. Green tea intake, MTHFR/TYMS genotype and breast cancer risk: the Singapore Chinese health study. Carcinogenesis 2008, 29(10):1967-1972.
16. Inoue M., Tajima K., Mizutani M., Iwata H., Iwase T., Miura S., et al. Regular consumption of green tea and the risk of breast cancer recurrence: follow-up study from the Hospital-based Epidemiologic Research Program at Aichi Cancer Center (HERPACC), Japan. Cancer Lett 2001, 167(2):175-182.
17. Nakachi K., Suemasu K., Suga K., Takeo T., Imai K., Higashi Y. Influence of drinking green tea on breast cancer malignancy among Japanese patients. Jpn J Cancer Res 1998, 89(3):254-261.
18. Ogunleye A.A., Xue F., Michels K.B. Green tea consumption and breast cancer risk or recurrence: a meta-analysis. Breast Cancer Res Treat 2010, 119(2):477-484.
19. Shrubsole M.J., Lu W., Chen Z., Shu X.O., Zheng Y., Dai Q., et al. Drinking green tea modestly reduces breast cancer risk. J Nutr 2009, 139(2):310-316.
20. Zhang M., Holman C.D.J., Huang J.P., Xie X. Green tea and the prevention of breast cancer: a case-control study in Southeast China. Carcinogenesis 2007, 28(5):1074-1078.
21. Wu A.H., Tseng C.C., Van den Berg D., Yu M.C. Tea intake, COMT genotype, and breast cancer in Asian-American women. Cancer Res 2003, 63(21):7526-7529.
22. Wu A.H., Yu M.C., Tseng C.C., Hankin J., Pike M.C. Green tea and risk of breast cancer in Asian Americans. Int J Cancer 2003, 106(4):574-579.
23. Ide R., Fujino Y., Hoshiyama Y., Mizoue T., Kubo T., Pham T.M., et al. A prospective study of green tea consumption and oral cancer incidence in Japan. Ann Epidemiol 2007, 17(10):821-826.
24. Li Q., Kakizaki M., Kuriyama S., Sone T., Yan H., Nakaya N., et al. Green tea consumption and lung cancer risk: the Ohsaki study. Br J Cancer 2008, 99(7):1179-1184.
25. Wu M., Liu A.M., Kampman E., Zhang Z.F., van't Veer P., Wu D.L., et al. Green tea drinking, high tea temperature and esophageal cancer in high- and low-risk areas of Jiangsu Province, China: a population-based case-control study. Int J Cancer 2009, 124(8):1907-1913.
26. Zhong L.J., Goldberg M.S., Gao Y.T., Hanley J.A., Parent M.E., Jin F. A population-based case-control study of lung cancer and green tea consumption among women living in Shanghai, China. Epidemiology 2001, 12(6):695-700.
27. Chen Z.H., Chen Q., Xia H.Y., Lin J.R. Green tea drinking habits and esophageal cancer in southern China: a case-control study. Asian Pac J Cancer Prev 2011, 12(1):229-233.
28. Ishikawa A., Kuriyama S., Tsubono Y., Fukao A., Takahashi H., Tachiya H., et al. Smoking, alcohol drinking, green tea consumption and the risk of esophageal cancer in Japanese men. J Epidemiol 2006, 16(5):185-192.
29. Gao Y.T., McLaughlin J.K., Blot W.J., Ji B.T., Dai Q., Fraumeni J.F. Reduced risk of esophageal cancer-associated with green tea consumption. J Natl Cancer Inst 1994, 86(11):855-858.
30. Bonner M.R., Rothman N., Mumford J.L., He X.Z., Shen M., Welch R., et al. Green tea consumption, genetic susceptibility, PAH-rich smoky coal, and the risk of lung cancer. Mutat Res 2005, 582(1-2):53-60.
31. Lin I.H., Ho M.L., Chen H.Y., Lee H.S., Huang C.C., Chu Y.H., et al. Smoking, green tea consumption, genetic polymorphisms in the insulin-like growth factors and lung cancer risk. PLoS One 2012, 7(2):e30951.
32. Tang N.P., Wu Y.M., Zhou B., Wang B., Yu R.B. Green tea, black tea consumption and risk of lung cancer: A meta-analysis. Lung Cancer 2009, 65(3):274-283.
33. Kikuchi N., Ohmori K., Shimazu T., Nakaya N., Kuriyama S., Nishino Y., et al. No association between green tea and prostate cancer risk in Japanese men: the Ohsaki Cohort Study. Br J Cancer 2006, 95(3):371-373.
34. Nguyen M.M., Ahmann F.R., Nagle R.B., Hsu C.H., Tangrea J.A., Pames H.L., et al. Randomized, double-blind, placebo-controlled trial of Polyphenon E in prostate cancer patients before prostatectomy: evaluation of potential chemopreventive activities. Cancer Prev Res (Phila) 2012, 5(2):290-298.
35. Kurahashi N., Sasazuki S., Iwasaki M., Inoue M., Tsugane S., Grp J.S. Green tea consumption and prostate cancer risk in Japanese men: a prospective study. Am J Epidemiol 2008, 167(1):71-77.
36. Bettuzzi S., Brausi M., Rizzi F., Castagnetti G., Peracchia G., Corti A. Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: A preliminary report from a one-year proof-of-principle study. Cancer Res 2006, 66(2):1234-1240.
37. Bettuzzi S., Brausi M., Rizzi F., Peracchia G., Corti A. Inhibition of human prostate cancer progression by administration of green tea catechins: a two years later follow-up update. Eur Urol Suppl 2008, 7(3):279.
38. Jian L., Xie L.P., Lee A.H., Binns C.W. Protective effect of green tea against prostate cancer: a case-control study in southeast China. Int J Cancer 2004, 108(1):130-135.
39. Myung S.K., Bae W.K., Oh S.M., Kim Y., Ju W., Sung J., et al. Green tea consumption and risk of stomach cancer: a meta-analysis of epidemiologic studies. Int J Cancer 2009, 124(3):670-677.
40. Sasazuki S., Inoue M., Hanaoka T., Yamamoto S., Sobue T., Tsugane S., et al. Green tea consumption and subsequent risk of gastric cancer by subsite: the JPHC Study. Cancer Cause Control 2004, 15(5):483-491.
41. Sun C.L., Yuan J.M., Koh W.P., Lee H.P., Yu M.C. Green tea and black tea consumption in relation to colorectal cancer risk: the Singapore Chinese health study. Carcinogenesis 2007, 28(10):2143-2148.
42. Suzuki Y., Tsubono Y., Nakaya N., Koizumi Y., Shibuya D., Tsuji I. Green tea and the risk of colorectal cancer: Pooled analysis of two prospective studies in Japan. J Epidemiol 2005, 15(4):118-124.
43. Tsubono Y., Nishino Y., Komatsu S., Hsieh C., Kanemura S., Tsuji I., et al. Green tea and the risk of gastric cancer in Japan. N Engl J Med 2001, 344(9):632-636.
44. Yang G., Zheng W., Xiang Y.B., Gao J., Li H.L., Zhang X.L., et al. Green tea consumption and colorectal cancer risk: a report from the Shanghai Men's health study. Carcinogenesis 2011, 32(11):1684-1688.
45. Zhou Y., Li N., Zhuang W., Liu G.J., Wu T.X., Yao X., et al. Green tea and gastric cancer risk: meta-analysis of epidemiologic studies. Asia Pac J Clin Nutr 2008, 17(1):159-165.
46. Ji B.T., Chow W.H., Hsing A.W., McLaughlin J.K., Dai Q., Gao Y.T., et al. Green tea consumption and the risk of pancreatic and colorectal cancers. Int J Cancer 1997, 70(3):255-258.
47. Hoshiyama Y., Kawaguchi T., Miura Y., Mizoue T., Tokui N., Yatsuya H., et al. A prospective study of stomach cancer death in relation to green tea consumption in Japan. Br J Cancer 2002, 87(3):309-313.
48. Hoshiyama Y., Kawaguchi T., Miura Y., Mizoue T., Tokui N., Yatsuya H., et al. A nested case-control study of stomach cancer in relation to green tea consumption in Japan. Br J Cancer 2004, 90(1):135-138.
49. Inoue M., Sasazuki S., Wakai K., Suzuki T., Matsuo K., Shimazu T., et al. Green tea consumption and gastric cancer in Japanese: a pooled analysis of six cohort studies. Gut 2009, 58(10):1323-1332.
50. Mao X.Q., Jia X.F., Zhou G., Li L., Niu H., Li F.L., et al. Green tea drinking habits and gastric cancer in Southwest China. Asian Pac J Cancer Prev 2011, 12(9):2179-2182.
51. Mu L.N., Lu Q.Y., Yu S.Z., Jiang Q.W., Cao W., You N.C., et al. Green tea drinking and multigenetic index on the risk of stomach cancer in a Chinese population. Int J Cancer 2005, 116(6):972-983.
52. Setiawan V.W., Zhang Z.F., Yu G.P., Lu Q.Y., Li Y.L., Lu M.L., et al. Protective effect of green tea on the risks of chronic gastritis and stomach cancer. Int J Cancer 2001, 92(4):600-604.
53. Yang G., Shu X.O., Li H.L., Chow W.H., Ji B.T., Zhang X.L., et al. Prospective cohort study of green tea consumption and colorectal cancer risk in women. Cancer Epidemiol Biomarkers Prev 2007, 16(6):1219-1223.
54. Yu G.P., Hsieh C.C., Wang L.Y., Yu S.Z., Li X.L., Jin T.H. Green-tea consumption and risk of stomach-cancer - a population-based case-control study in Shanghai, China. Cancer Cause Control 1995, 6(6):532-538.
55. Lin Y.S., Kikuchi S., Tamakoshi A., Yagyu K., Obata Y., Kurosawa M., et al. Green tea consumption and the risk of pancreatic cancer in Japanese adults. Pancreas 2008, 37(1):25-30.
56. Luo J.H., Inoue M., Iwasaki M., Sasazuki S., Otani T., Ye W.M., et al. Green tea and coffee intake and risk of pancreatic cancer in a large-scale, population-based cohort study in Japan (JPHC study). Eur J Cancer Prev 2007, 16(6):542-548.
57. Nakamura K., Nagata C., Wada K., Tamai Y., Tsuji M., Takatsuka N., et al. Cigarette smoking and other lifestyle factors in relation to the risk of pancreatic cancer death: a prospective cohort study in Japan. Jpn J Clin Oncol 2011, 41(2):225-231.
58. Inoue M., Kurahashi N., Iwasaki M., Shimazu T., Tanaka Y., Mizokami M., et al. Effect of coffee and green tea consumption on the risk of liver cancer: cohort analysis by hepatitis virus infection status. Cancer Epidemiol Biomarkers Prev 2009, 18(6):1746-1753.
59. Li Y.L., Chang S.C., Goldstein B.Y., Scheider W.L., Cai L., You N.C.Y., et al. Green tea consumption, inflammation and the risk of primary hepatocellular carcinoma in a Chinese population. Cancer Epidemiol 2011, 35(4):362-368.
60. Ui A., Kuriyama S., Kakizaki M., Sone T., Nakaya N., Ohmori-Matsuda K., et al. Green tea consumption and the risk of liver cancer in Japan: the Ohsaki Cohort study. Cancer Cause Control 2009, 20(10):1939-1945.
61. Nagle C.M., Olsen C.M., Bain C.J., Whiteman D.C., Green A.C., Webb P.M. Tea consumption and risk of ovarian cancer. Cancer Cause Control 2010, 21(9):1485-1491.
62. Zhang M., Lee A.H., Binns C.W., Xie X. Green tea consumption enhances survival of epithelial ovarian cancer. Int J Cancer 2004, 112(3):465-469.
63. Hemelt M., Hu Z.Q., Zhong Z.H., Xie L.P., Wong Y.C., Tam P.C., et al. Fluid intake and the risk of bladder cancer: results from the South and East China case-control study on bladder cancer. Int J Cancer 2010, 127(3):638-645.
64. Wang G.P., Hou J.G., Ma L.Y., Xie J.X., Yin J.H., Xu D.F., et al. Risk factor for clear cell renal cell carcinoma in Chinese population: A case-control study. Cancer Epidemiol 2012, 36(2):177-182.
65. Michikawa T., Inoue M., Shimazu T., Sasazuki S., Iwasaki M., Sawada N., et al. Green tea and coffee consumption and its association with thyroid cancer risk: a population-based cohort study in Japan. Cancer Cause Control 2011, 22(7):985-993.
66. Lee T.C., Cheng I.C., Shue J.J., Wang T.C. Cytotoxicity of arsenic trioxide is enhanced by (-)-epigallocatechin-3-gallate via suppression of ferritin in cancer cells. Toxicol Appl Pharmacol 2011, 250(1):69-77.
67. Kweon M.H., Adhami V.M., Lee J.S., Mukhtar H. Constitutive overexpression of Nrf2-dependent heme oxygenase-1 in A549 cells contributes to resistance to apoptosis induced by epigallocatechin 3-gallate. J Biol Chem 2006, 281(44):33761-33772.
68. Azam S., Hadi N., Khan N.U., Hadi S.M. Prooxidant property of green tea polyphenols epicatechin and epigallocatechin-3-gallate: implications for anticancer properties. Toxicol Vitro 2004, 18(5):555-561.
69. Kinjo J., Nagao T., Tanaka T., Nonaka G., Okawa M., Nohara T., et al. Activity-guided fractionation of green tea extract with antiproliferative activity against human stomach cancer cells. Biol Pharmacol Bull 2002, 25(9):1238-1240.
70. Tsukamoto S., Yamashita S., Kim Y.H., Kumazoe M., Huang Y.H., Yamada K., et al. Oxygen partial pressure modulates 67-kDa laminin receptor expression, leading to altered activity of the green tea polyphenol, EGCG. FEBS Lett 2012, 586(19):3441-3447.
71. Yamamoto T., Hsu S., Lewis J., Wataha J., Dickinson D., Singh B., et al. Green tea polyphenol causes differential oxidative environments in tumor versus normal epithelial cells. J Pharmacol Exp Ther 2003, 307(1):230-236.
72. Rathore K., Choudhary S., Odoi A., Wang H.C.R. Green tea catechin intervention of reactive oxygen species-mediated ERK pathway activation and chronically induced breast cell carcinogenesis. Carcinogenesis 2012, 33(1):174-183.
73. Rathore K., Wang H.C.R. Green tea catechin extract in intervention of chronic breast cell carcinogenesis induced by environmental carcinogens. Mol Carcinog 2012, 51(3):280-289.
74. Artali R., Beretta G., Morazzoni P., Bombardelli E., Meneghetti F. Green tea catechins in chemoprevention of cancer: A molecular docking investigation into their interaction with glutathione S-transferase (GST P1-1). J Enzym Inhib Med Chem 2009, 24(1):287-295.
75. Fujimura Y., Sumida M., Sugihara K., Tsukamoto S., Yamada K., Tachibana H. Green tea polyphenol EGCG sensing motif on the 67-kDa laminin receptor. PLoS One 2012, 7(5):e37942.
76. Urusova D.V., Shim J.H., Kim D.J., Jung S.K., Zykova T.A., Carper A., et al. Epigallocatechin-gallate suppresses tumorigenesis by directly targeting Pin1. Cancer Prev Res 2011, 4(9):1366-1377.
77. Tanaka T., Ishii T., Mizuno D., Mori T., Yamaji R., Nakamura Y., et al. (-)-Epigallocatechin-3-gallate suppresses growth of AZ521 human gastric cancer cells by targeting the DEAD-box RNA helicase p68. Free Radic Biol Med 2011, 50(10):1324-1335.
78. Ishii T., Mori T., Tanaka T., Mizuno D., Yamaji R., Kumazawa S., et al. Covalent modification of proteins by green tea polyphenol (-)-epigallocatechin-3-gallate through autoxidation. Free Radic Biol Med 2008, 45(10):1384-1394.
79. Lambert J.D., Sang S.M., Hong J., Yang C.S. Anticancer and anti-inflammatory effects of cysteine metabolites of the green tea polyphenol, (-)-epigallocatechin-3-gallate. J Agric Food Chem 2010, 58(18):10016-10019.
80. Lu Y., Yao R.S., Yan Y., Wang Y., Hara Y., Lubet R.A., et al. A gene expression signature that can predict green tea exposure and chemopreventive efficacy of lung cancer in mice. Cancer Res 2006, 66(4):1956-1963.
81. Qiao J.P., Gu C.X., Shang W.H., Du J.L., Yin W., Zhu M.L., et al. Effect of green tea on pharmacokinetics of 5-fluorouracil in rats and pharmacodynamics in human cell lines in vitro. Food Chem Toxicol 2011, 49(6):1410-1415.
82. Suzuki Y., Tsubono Y., Nakaya N., Koizumi Y., Tsuji I. Green tea and the risk of breast cancer: pooled analysis of two prospective studies in Japan. Br J Cancer 2004, 90(7):1361-1363.
83. Dai Q., Shu X.O., Li H.L., Yang G., Shrubsole M.J., Cai H., et al. Is green tea drinking associated with a later onset of breast cancer?. Ann Epidemiol 2010, 20(1):74-81.
84. Lu H., Meng X.F., Yang C.S. Enzymology of methylation of tea catechins and inhibition of catechol-O-methyltransferase by (-)-epigallocatechin gallate. Drug Metab Dispos 2003, 31(5):572-579.
85. Kavanagh K.T., Hafer L.J., Kim D.W., Mann K.K., Sherr D.H., Rogers A.E., et al. Green tea extracts decrease carcinogen-induced mammary tumor burden in rats and rate of breast cancer cell proliferation in culture. J Cell Biochem 2001, 82(3):387-398.
86. Thangapazham R.L., Singh A.K., Sharma A., Warren J., Gaddipati J.P., Maheshwari R.K. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo. Cancer Lett 2007, 245(1-2):232-241.
87. Sakata M., Ikeda T., Imoto S., Jinno H., Kitagawa Y. Prevention of mammary carcinogenesis in C3H/OuJ mice by green tea and tamoxifen. Asian Pac J Cancer Prev 2011, 12(2):567-571.
88. Schwartz J.L., Baker V., Larios E., Chung F.L. Molecular and cellular effects of green tea on oral cells of smokers: A pilot study. Mol Nutr Food Res 2005, 49(1):43-51.
89. Cui Y., Morgenstern H., Greenland S., Tashkin D.P., Mao J.T., Cai L., et al. Dietary flavonoid intake and lung cancer - a population-based case-control study. Cancer 2008, 112(10):2241-2248.
90. Chen P.N., Chu S.C., Kuo W.H., Chou M.Y., Lin J.K., Hsieh Y.S. Epigallocatechin-3 gallate inhibits invasion, epithelial-mesenchymal transition, and tumor growth in oral cancer cells. J Agric Food Chem 2011, 59(8):3836-3844.
91. Koh Y.W., Choia E.C., Kang S.U., Hwang H.S., Lee M.H., Pyun J., et al. Green tea (-)-epigallocatechin-3-gallate inhibits HGF-induced progression in oral cavity cancer through suppression of HGF/c-Met. J Nutr Biochem 2011, 22(11):1074-1083.
92. Lambert J.D., Kwon S.J., Hong J., Yang C.S. Salivary hydrogen peroxide produced by holding or chewing green tea in the oral cavity. Free Radic Res 2007, 41(7):850-853.
93. Mohan K., Hara Y., Abraham S.K., Nagini S. Comparative evaluation of the chemopreventive efficacy of green and black tea polyphenols in the hamster buccal pouch carcinogenesis model. Clin Biochem 2005, 38(10):879-886.
94. Li G.X., Chen Y.K., Hou Z., Xiao H., Jin H.Y., Lu G., et al. Pro-oxidative activities and dose-response relationship of (-)-epigallocatechin-3-gallate in the inhibition of lung cancer cell growth: a comparative study in vivo and in vitro. Carcinogenesis 2010, 31(5):902-910.
95. Milligan S.A., Burke P., Coleman D.T., Bigelow R.L., Steffan J.J., Carrol J.L., et al. The green tea polyphenol EGCG potentiates the antiproliferative activity of c-Met and epidermal growth factor receptor inhibitors in non-small cell lung cancer cells. Clin Cancer Res 2009, 15(15):4885-4894.
96. Zhang Q., Fu H.J., Pan J., He J., Ryota S., Hara Y., et al. Effect of dietary Polyphenon E and EGCG on lung tumorigenesis in A/J mice. Pharm Res 2010, 27(6):1066-1071.
97. Siddiqui I.A., Asim M., Hafeez B.B., Adhami V.M., Tarapore R.S., Mukhtar H. Green tea polyphenol EGCG blunts androgen receptor function in prostate cancer. FASEB J 2011, 25(4):1198-1207.
98. Brizuela L., Dayon A., Doumerc N., Ader I., Golzio M., Izard J.C., et al. The sphingosine kinase-1 survival pathway is a molecular target for the tumor-suppressive tea and wine polyphenols in prostate cancer. FASEB J 2010, 24(10):3882-3894.
99. Adhami V.M., Siddiqui I.A., Ahmad N., Gupta S., Mukhtar H. Oral consumption of green tea polyphenols inhibits insulin-like growth factor-i-induced signaling in an autochthonous mouse model of prostate cancer. Cancer Res 2004, 64(23):8715-8722.
100. Stearns M.E., Amatangelo M.D., Varma D., Sell C., Goodyear S.M. Combination therapy with epigallocatechin-3-gallate and doxorubicin in human prostate tumor modeling studies: inhibition of metastatic tumor growth in severe combined immunodeficiency mice. Am J Pathol 2010, 177(6):3169-3179.
101. Stearns M.E., Wang M. Synergistic effects of the green tea extract epigallocatechin-3-gallate and taxane in eradication of malignant human prostate tumors. Transl Oncol 2011, 4(3):147-156.
102. Yuasa Y., Nagasaki H., Akiyama Y., Hashimoto Y., Takizawa T., Kojima K., et al. DNA methylation status is inversely correlated with green tea intake and physical activity in gastric cancer patients. Int J Cancer 2009, 124(11):2677-2682.
103. Yin P.Z., Zhao J.Y., Cheng S.J., Hara Y., Zhu Q.F., Liu Z.G. Experimental studies of the inhibitory effects of green tea catechin on mice large intestinal cancers induced by 1,2-dimethylhydrazine. Cancer Lett 1994, 79(1):33-38.
104. Yuan J.H., Li Y.Q., Yang X.Y. Inhibition of epigallocatechin gallate on orthotopic colon cancer by upregulating the Nrf2-UGT1A signal pathway in nude mice. Pharmacology 2007, 80(4):269-278.
105. Shimizu M., Shirakami Y., Sakai H., Yasuda Y., Kubota M., Adachi S., et al. (-)-Epigallocatechin gallate inhibits growth and activation of the VEGF/VEGFR axis in human colorectal cancer cells. Chem Biol Interact 2010, 185(3):247-252.
106. Hao X.P., Bose M., Lambert J.D., Ju J.Y., Lu G., Lee M.J., et al. Inhibition of intestinal tumorigenesis in Apc(Min/+) mice by green tea polyphenols (Polyphenon E) and individual catechins. Nutr Cancer 2007, 59(1):62-69.
107. Ju J., Hong J., Zhou J.N., Pan Z., Bose M., Liao J., et al. Inhibition of intestinal tumorigenesis in Apc(min/+) mice by (-)-epigallocatechin-3-gallate, the major catechin in green tea. Cancer Res 2005, 65(22):10623-10631.
108. Sukhthankar M., Yamaguchi K., Lee S.H., McEntee M.F., Eling T.E., Hara Y., et al. A green tea component suppresses posttranslational expression of basic fibroblast growth factor in colorectal cancer. Gastroenterology 2008, 134(7):1972-1980.
109. Wu H.J., Xin Y., Xu C.A., Xiao Y.P. Capecitabine combined with (-)-epigallocatechin-3-gallate inhibits angiogenesis and tumor growth in nude mice with gastric cancer xenografts. Exp Ther Med 2012, 3(4):650-654.
110. Kim M., Murakami A., Miyamoto S., Tanaka T., Ohigashi H. The modifying effects of green tea polyphenols on acute colitis and inflammation-associated colon carcinogenesis in male ICR mice. Biofactors 2010, 36(1):43-51.
111. Ran Z.H., Chen C., Xiao S.D. Epigallocatechin-3-gallate ameliorates rats colitis induced by acetic acid. Biomed Pharmacother 2008, 62(3):189-196.
112. Khatiwada J., Verghese M., Davis S., Williams L.L. Green tea, phytic acid, and inositol in combination reduced the incidence of azoxymethane-induced colon tumors in Fisher 344 male rats. J Med Food 2011, 14(11):1313-1320.
113. Xu Q., Yang C.H., Liu Q., Jin X.F., Xu X.T., Tong J.L., et al. Chemopreventive effect of epigallocatechin-3-gallate (EGCG) and folic acid on the N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)-induced gastrointestinal cancer in rat model. J Dig Dis 2011, 12(3):181-187.
114. Hiura A., Tsutsumi M., Satake K. Inhibitory effect of green tea extract on the process of pancreatic carcinogenesis induced by N-nitrosobis-(2-oxypropyl)amine (BOP) and on tumor promotion after transplantation of N-nitrosobis-(2-hydroxypropyl)amine (BHP)-induced pancreatic cancer in Syrian hamsters. Pancreas 1997, 15(3):272-277.
115. Liang G., Tang A.Z., Lin X.Z., Li L., Zhang S., Huang Z.M., et al. Green tea catechins augment the antitumor activity of doxorubicin in an in vivo mouse model for chemoresistant liver cancer. Int J Oncol 2010, 37(1):111-123.
116. Shimizu M., Sakai H., Shirakami Y., Yasuda Y., Kubota M., Terakura D., et al. Preventive effects of (-)-epigallocatechin gallate on diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BL/KsJ-db/db mice. Cancer Prev Res 2011, 4(3):396-403.
117. Zhang D., Al-Hendy M., Richard-Davis G., Montgomery-Rice V., Sharan C., Rajaratnam V., et al. Green tea extract inhibits proliferation of uterine leiomyoma cells in vitro and in nude mice. Am J Obstet Gynecol 2010, 202(3). 289. e1-9.
118. Chen N.G., Lu C.C., Lin Y.H., Shen W.C., Lai C.H., Ho Y.J., et al. Proteomic approaches to study epigallocatechin gallate-provoked apoptosis of TSGH-8301 human urinary bladder carcinoma cells: Roles of AKT and heat shock protein 27-modulated intrinsic apoptotic pathways. Oncol Rep 2011, 26(4):939-947.
119. Sagara Y., Miyata Y., Nomata K., Hayashi T., Kanetake H. Green tea polyphenol suppresses tumor invasion and angiogenesis in N-butyl-(4-hydroxybutyl) nitrosamine-induced bladder cancer. Cancer Epidemiol 2010, 34(3):350-354.
120. Hirose M., Hoshiya T., Mizoguchi Y., Nakamura A., Akagi K., Shirai T. Green tea catechins enhance tumor development in the colon without effects in the lung or thyroid after pretreatment with 1,2-dimethylhydrazine or 2,2'-dihydroxy-di-n-propylnitrosamine in male F344 rats. Cancer Lett 2001, 168(1):23-29.
121. Wang Z.Y., Khan W.A., Bickers D.R., Mukhtar H. Protection against polycyclic aromatic hydrocarbon-induced skin tumor initiation in mice by green tea polyphenols. Carcinogenesis 1989, 10(2):411-415.
122. Barthelman M., Bair W.B., Stickland K.K., Chen W.X., Timmermann N., Valcic S., et al. (-)-epigallocatechin-3-gallate inhibition of ultraviolet B induced AP-1 activity. Carcinogenesis 1998, 19(12):2201-2204.
123. Nakazato T., Ito K., Miyakawa Y., Kinjo K., Hozumi N., Ikeda Y., et al. Catechin, a green tea component, rapidly induces apoptosis of myeloid leukemic cells via modulation of reactive oxygen species production in vitro and inhibits tumor growth in vivo. Haematologica 2005, 90(3):317-325.
124. Tsukamoto S., Hirotsu K., Kumazoe M., Goto Y., Sugihara K., Suda T., et al. Green tea polyphenol EGCG induces lipid-raft clustering and apoptotic cell death by activating protein kinase Cδ and acid sphingomyelinase through a 67kDa laminin receptor in multiple myeloma cells. Biochem J 2012, 443:525-534.
125. Landis-Piwowar K.R., Wan S.B., Wiegand R.A., Kuhn D.J., Chan T.H., Dou Q.P. Methylation suppresses the proteasome-inhibitory function of green tea polyphenols. J Cell Physiol 2007, 213(1):252-260.
126. Lu H., Meng X.F., Li C., Sang S.M., Patten C., Sheng S.Q., et al. Glucuronides of tea catechins: enzymology of biosynthesis and biological activities. Drug Metab Dispos 2003, 31(4):452-461.
127. Tamura H., Matsui M. Inhibitory effects of green tea and grape juice on the phenol sulfotransferase activity of mouse intestines and human colon carcinoma cell line, Caco-2. Biol Pharmacol Bull 2000, 23(6):695-699.
128. Lambert J.D., Sang S.M., Hong J., Kwon S.J., Lee M.J., Ho C.T., et al. Peracetylation as a means of enhancing in vitro bioactivity and bioavailability of epigallocatechin-3-gallate. Drug Metab Dispos 2006, 34(12):2111-2116.
129. Chiou Y.S., Ma N., Sang S.M., Ho C.T., Wang Y.J., Pan M.H. Peracetylated (-)-epigallocatechin-3-gallate (AcEGCG) potently suppresses dextran sulfate sodium-induced colitis and colon tumorigenesis in mice. J Agric Food Chem 2012, 60(13):3441-3451.
130. Proniuk S., Liederer B.M., Blanchard J. Preformulation study of epigallocatechin gallate, a promising antioxidant for topical skin cancer prevention. J Pharm Sci 2002, 91(1):111-116.
131. Lambert J.D., Kennett M.J., Sang S.M., Reuhl K.R., Ju J., Yang C.S. Hepatotoxicity of high oral dose (-)-epigallocatechin-3-gallate in mice. Food Chem Toxicol 2010, 48(1):409-416.
132. Choan E., Segal R., Jonker D., Malone S., Reaume N., Eapen L., et al. A prospective clinical trial of green tea for hormone refractory prostate cancer: an evaluation of the complementary/alternative therapy approach. Urol Oncol 2005, 23(2):108-113.
133. Chow H.H.S., Cai Y., Hakim I.A., Crowell J.A., Shahi F., Brooks C.A., et al. Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and Polyphenon E in healthy individuals. Clin Cancer Res 2003, 9(9):3312-3319.
134. Laurie S.A., Miller V.A., Grant S.C., Kris M.G., Ng K.K. Phase I study of green tea extract in patients with advanced lung cancer. Cancer Chemother Pharmacol 2005, 55(1):33-38.
135. Lambert J.D., Hong J.G., Kim D.H., Mishin V.M., Yang C.S. Piperine enhances the bioavailability of the tea polyphenol (-)-epigallocatechin-3-gallate in mice. J Nutr 2004, 134(8):1948-1952.